Abstract:As a degenerative joint disease, osteoarthritis (OA) constitutes a major cause of disability that seriously affects the quality of life of a large population of people worldwide. However, effective treatment that can successfully reverse OA progression is lacking until now. The present study aimed to determine whether two small non-coding RNAs miR-29a and miR-140, which are significantly down-regulated in OA, can be applied together as potential therapeutic targets for OA treatment. MiRNA synergy score was used to screen the miRNA pairs that potentially synergistically regulate OA. An in vitro model of OA was established by treating murine chondrocytes with IL-1β. Transfection of miR-29a and miR-140 via plasmids was investigated on chondrocyte proliferation and expression of nine genes such as ADAMTS4, ADAMTS5, ACAN, COL2A1, COL10A1, MMP1, MMP3, MMP13 and TIMP metal-lopeptidase inhibitor 1 (TIMP1). Western blotting was used to determine the protein expression level of MMP13 and TIMP1, and ELISA was used to detect the content of type II collagen. Combined use of miR-29a and miR-140 successfully reversed the destructive effect of IL-1β on chondrocyte proliferation, and notably affected the MMP13 and TIMP1 gene expression that regulates extracellular matrix. Although co-transfection of miR-29a and miR-140 did not show a synergistic effect on MMP13 protein expression and type II collagen release, but both of them can significantly suppress the protein abundance of MMP13 and restore the type II collagen release in IL-1β treated chondrocytes. Compared with single miRNA transfection, cotransfection of both miRNAs exceedingly abrogated the suppressed the protein production of TIMP1 caused by IL-1β, thereby suggesting potent synergistic action. These results provided novel insights into the important function of miRNAs' collaboration in OA pathological development. The reduced MMP13, and enhanced TIMP1 protein production and type II collagen release also implies that miR-29a and miR-140 combination treatment may be a possible treatment for OA.

Mir‐382‐3p Suppressed IL‐1β Induced Inflammatory Response of Chondrocytes Via the TLR4/MyD88/NF‐κB Signaling Pathway by Directly Targeting CX43

Role of the Cirs-7/Mir-7 Axis in the Regulation of Proliferation, Apoptosis and Inflammation of Chondrocytes Induced by IL-1β.

The pro-inflammatory effect of NR4A3 in osteoarthritis

The Mir-302C/transforming Growth Factor-Β Receptor Type-2 Axis Modulates Interleukin-1Β-induced Degenerative Changes in Osteoarthritic Chondrocytes

Mir-373 Regulates Inflammatory Cytokine-Mediated Chondrocyte Proliferation in Osteoarthritis by Targeting the P2X7 Receptor

The Elevated Expression of IL-38 Serves As an Anti-Inflammatory Factor in Osteoarthritis and Its Protective Effect in Osteoarthritic Chondrocytes.

Targeting Mir-18A Sensitizes Chondrocytes to Anticytokine Therapy to Prevent Osteoarthritis Progression

MicroRNA-410-3p modulates chondrocyte apoptosis and inflammation by targeting high mobility group box 1 (HMGB1) in an osteoarthritis mouse model

Inhibition of Microrna-495 Suppresses Chondrocyte Apoptosis Through Activation of the NF-κB Signaling Pathway by Regulating CCL4 in Osteoarthritis

Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 Β-Induced Inflammation Via Up-regulating SOX9.

Mir-93-5p Attenuates IL-1β-induced Chondrocyte Apoptosis and Cartilage Degradation in Osteoarthritis Partially by Targeting TCF4

Mir‐193b‐5p Regulates Chondrocytes Metabolism by Directly Targeting Histone Deacetylase 7 in Interleukin‐1β‐induced Osteoarthritis

MiR-375 Mediates Chondrocyte Metabolism and Oxidative Stress in Osteoarthritis Mouse Models through the JAK2/STAT3 Signaling Pathway.

MiR-375 Mediates Chondrocyte Metabolism and Oxidative Stress in Osteoarthritis Mouse Models through the JAK2/STAT3 Signaling Pathway

MicroRNA-27a Alleviates IL-1β-induced Inflammatory Response and Articular Cartilage Degradation Via TLR4/NF-κB Signaling Pathway in Articular Chondrocytes

Microrna-193b-3p Regulates Matrix Metalloproteinase 19 Expression In Interleukin-1 Beta-Induced Human Chondrocytes

MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β

MiR-485-3p Promotes Proliferation of Osteoarthritis Chondrocytes and Inhibits Apoptosis Via Notch2 and the NF-κB Pathway.

The Role of MicroRNA-381 in Chondrogenesis and Interleukin-1-β Induced Chondrocyte Responses

MicroRNA-377–3p Alleviates IL-1β-caused Chondrocyte Apoptosis and Cartilage Degradation in Osteoarthritis in Part by Downregulating ITGA6

MicroRNA-140-5p represses chondrocyte pyroptosis and relieves cartilage injury in osteoarthritis by inhibiting cathepsin B/Nod-like receptor protein 3